Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 47 | 2023 | 147 | 13.720 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2023 | 767 | 5.190 |
Why?
|
| Aging | 31 | 2023 | 664 | 4.960 |
Why?
|
| Aged, 80 and over | 47 | 2023 | 2379 | 2.420 |
Why?
|
| Japan | 43 | 2021 | 305 | 2.360 |
Why?
|
| Genotype | 19 | 2023 | 730 | 2.170 |
Why?
|
| Forkhead Transcription Factors | 7 | 2022 | 76 | 2.090 |
Why?
|
| Hypertension | 8 | 2023 | 796 | 1.890 |
Why?
|
| Life Expectancy | 7 | 2016 | 42 | 1.540 |
Why?
|
| Aged | 43 | 2023 | 6741 | 1.530 |
Why?
|
| Alleles | 9 | 2023 | 321 | 1.450 |
Why?
|
| Male | 78 | 2023 | 20025 | 1.420 |
Why?
|
| Humans | 102 | 2023 | 37093 | 1.310 |
Why?
|
| Coronary Disease | 7 | 2020 | 124 | 1.210 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 114 | 1.130 |
Why?
|
| Coronary Artery Disease | 7 | 2017 | 142 | 1.120 |
Why?
|
| Mortality | 6 | 2016 | 145 | 1.080 |
Why?
|
| Phenotype | 7 | 2020 | 689 | 1.050 |
Why?
|
| Risk Factors | 35 | 2023 | 3562 | 1.050 |
Why?
|
| Cognition Disorders | 4 | 2022 | 233 | 1.010 |
Why?
|
| Stroke | 4 | 2023 | 286 | 0.990 |
Why?
|
| Caloric Restriction | 5 | 2016 | 32 | 0.950 |
Why?
|
| Prospective Studies | 17 | 2023 | 1378 | 0.880 |
Why?
|
| Case-Control Studies | 9 | 2020 | 1130 | 0.880 |
Why?
|
| Apolipoprotein E2 | 1 | 2022 | 6 | 0.860 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 190 | 0.860 |
Why?
|
| Genetic Variation | 5 | 2021 | 387 | 0.820 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 78 | 0.800 |
Why?
|
| Longitudinal Studies | 11 | 2023 | 885 | 0.750 |
Why?
|
| Hawaii | 19 | 2022 | 1929 | 0.750 |
Why?
|
| Proteomics | 1 | 2023 | 325 | 0.740 |
Why?
|
| Cognition | 8 | 2022 | 398 | 0.740 |
Why?
|
| Life Style | 8 | 2021 | 308 | 0.690 |
Why?
|
| Health Behavior | 2 | 2014 | 537 | 0.670 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 333 | 0.660 |
Why?
|
| Middle Aged | 36 | 2022 | 10129 | 0.660 |
Why?
|
| Diet | 5 | 2022 | 801 | 0.650 |
Why?
|
| Cardiovascular Diseases | 7 | 2021 | 664 | 0.640 |
Why?
|
| Population Dynamics | 2 | 2016 | 35 | 0.640 |
Why?
|
| Leukocytes | 1 | 2018 | 72 | 0.630 |
Why?
|
| Cause of Death | 4 | 2017 | 156 | 0.610 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 18 | 0.610 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 18 | 0.610 |
Why?
|
| Insulin | 3 | 2014 | 236 | 0.590 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2022 | 36 | 0.590 |
Why?
|
| Signal Transduction | 2 | 2018 | 1908 | 0.570 |
Why?
|
| Blood Pressure | 3 | 2017 | 646 | 0.560 |
Why?
|
| Female | 36 | 2023 | 20969 | 0.560 |
Why?
|
| Risk Assessment | 9 | 2020 | 753 | 0.550 |
Why?
|
| Gene Frequency | 5 | 2018 | 195 | 0.530 |
Why?
|
| Cohort Studies | 8 | 2020 | 1492 | 0.500 |
Why?
|
| Functional Food | 2 | 2014 | 2 | 0.500 |
Why?
|
| Antioxidants | 3 | 2023 | 416 | 0.500 |
Why?
|
| Body Height | 2 | 2014 | 53 | 0.490 |
Why?
|
| Body Mass Index | 11 | 2021 | 854 | 0.490 |
Why?
|
| Overweight | 2 | 2014 | 247 | 0.480 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2014 | 22 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 643 | 0.470 |
Why?
|
| Aortic Diseases | 3 | 2019 | 27 | 0.460 |
Why?
|
| Forecasting | 1 | 2014 | 128 | 0.460 |
Why?
|
| Climate Change | 1 | 2013 | 35 | 0.450 |
Why?
|
| Dementia, Vascular | 2 | 2023 | 36 | 0.430 |
Why?
|
| United States | 17 | 2019 | 4223 | 0.430 |
Why?
|
| Age Factors | 9 | 2020 | 1033 | 0.430 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 191 | 0.420 |
Why?
|
| Health Status | 5 | 2014 | 380 | 0.410 |
Why?
|
| Open Reading Frames | 1 | 2012 | 77 | 0.410 |
Why?
|
| Haplotypes | 3 | 2018 | 182 | 0.410 |
Why?
|
| Carrier Proteins | 1 | 2014 | 305 | 0.400 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2023 | 19 | 0.390 |
Why?
|
| Heat-Shock Proteins | 2 | 2023 | 55 | 0.370 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 2 | 2021 | 13 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 628 | 0.350 |
Why?
|
| Eicosapentaenoic Acid | 3 | 2022 | 14 | 0.340 |
Why?
|
| Docosahexaenoic Acids | 3 | 2022 | 18 | 0.340 |
Why?
|
| Morbidity | 2 | 2016 | 91 | 0.340 |
Why?
|
| Heterozygote | 3 | 2018 | 93 | 0.330 |
Why?
|
| Adult | 24 | 2022 | 11712 | 0.330 |
Why?
|
| Cross-Sectional Studies | 13 | 2022 | 2721 | 0.320 |
Why?
|
| Follow-Up Studies | 8 | 2016 | 974 | 0.320 |
Why?
|
| Cardiovascular System | 1 | 2008 | 33 | 0.310 |
Why?
|
| Energy Intake | 2 | 2009 | 170 | 0.310 |
Why?
|
| Circumcision, Male | 2 | 2017 | 8 | 0.290 |
Why?
|
| Siblings | 1 | 2006 | 18 | 0.270 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 905 | 0.260 |
Why?
|
| Animals | 10 | 2023 | 15081 | 0.250 |
Why?
|
| Apolipoproteins E | 2 | 2022 | 129 | 0.250 |
Why?
|
| Health | 3 | 2009 | 30 | 0.240 |
Why?
|
| Alcohol Drinking | 3 | 2018 | 519 | 0.240 |
Why?
|
| Anthropometry | 2 | 2017 | 97 | 0.240 |
Why?
|
| Curcuma | 2 | 2014 | 5 | 0.240 |
Why?
|
| Asia | 2 | 2023 | 75 | 0.240 |
Why?
|
| Lipoproteins, HDL | 2 | 2018 | 46 | 0.240 |
Why?
|
| Dietary Carbohydrates | 2 | 2016 | 31 | 0.240 |
Why?
|
| Phenylbutyrates | 1 | 2023 | 5 | 0.240 |
Why?
|
| Flavonols | 1 | 2023 | 16 | 0.230 |
Why?
|
| Nerve Regeneration | 1 | 2004 | 40 | 0.230 |
Why?
|
| Reference Values | 2 | 2014 | 212 | 0.230 |
Why?
|
| Genetics | 1 | 2023 | 9 | 0.230 |
Why?
|
| Hydrogen Sulfide | 1 | 2023 | 39 | 0.230 |
Why?
|
| Cholesterol | 4 | 2015 | 205 | 0.230 |
Why?
|
| Financing, Personal | 1 | 2023 | 9 | 0.230 |
Why?
|
| Retirement | 1 | 2023 | 10 | 0.230 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 149 | 0.220 |
Why?
|
| Gene Expression | 2 | 2014 | 674 | 0.220 |
Why?
|
| Prevalence | 6 | 2020 | 1455 | 0.220 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 188 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 161 | 0.210 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 583 | 0.210 |
Why?
|
| Apolipoprotein E4 | 1 | 2022 | 47 | 0.210 |
Why?
|
| Phospholipids | 1 | 2022 | 70 | 0.210 |
Why?
|
| Proportional Hazards Models | 5 | 2014 | 441 | 0.200 |
Why?
|
| Incidence | 8 | 2023 | 922 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 360 | 0.200 |
Why?
|
| Receptors, Somatotropin | 1 | 2021 | 12 | 0.200 |
Why?
|
| Sex Factors | 3 | 2020 | 898 | 0.200 |
Why?
|
| Cholesterol, HDL | 3 | 2018 | 97 | 0.190 |
Why?
|
| Heart Diseases | 1 | 2022 | 104 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 103 | 0.190 |
Why?
|
| Survival Analysis | 3 | 2021 | 325 | 0.190 |
Why?
|
| Obesity | 4 | 2018 | 1067 | 0.180 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 146 | 0.180 |
Why?
|
| Adiposity | 2 | 2018 | 154 | 0.180 |
Why?
|
| Smoking | 6 | 2018 | 940 | 0.170 |
Why?
|
| Chromatin | 2 | 2018 | 169 | 0.170 |
Why?
|
| Pediatrics | 2 | 2017 | 68 | 0.170 |
Why?
|
| Sirtuins | 1 | 2018 | 12 | 0.160 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 85 | 0.160 |
Why?
|
| Abdominal Fat | 1 | 2018 | 21 | 0.160 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 30 | 0.160 |
Why?
|
| Hydra | 1 | 2018 | 4 | 0.160 |
Why?
|
| Leukocyte Count | 2 | 2015 | 77 | 0.160 |
Why?
|
| Fasting | 3 | 2014 | 54 | 0.160 |
Why?
|
| Sarcopenia | 1 | 2017 | 10 | 0.150 |
Why?
|
| Republic of Korea | 5 | 2018 | 107 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 245 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 448 | 0.150 |
Why?
|
| Laminin | 1 | 2017 | 61 | 0.150 |
Why?
|
| Nutritional Status | 2 | 2016 | 116 | 0.150 |
Why?
|
| Population | 1 | 2016 | 10 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 474 | 0.140 |
Why?
|
| Neurons | 1 | 2004 | 1175 | 0.140 |
Why?
|
| Seafood | 2 | 2014 | 23 | 0.140 |
Why?
|
| Quality of Life | 2 | 2014 | 481 | 0.140 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 52 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 75 | 0.140 |
Why?
|
| Genome, Human | 1 | 2017 | 135 | 0.140 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 6 | 0.140 |
Why?
|
| Brain | 2 | 2023 | 1346 | 0.140 |
Why?
|
| Dietary Proteins | 1 | 2016 | 32 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 219 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 214 | 0.130 |
Why?
|
| Binding Sites | 1 | 2017 | 651 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2016 | 210 | 0.130 |
Why?
|
| Base Sequence | 1 | 2017 | 997 | 0.130 |
Why?
|
| Calcinosis | 2 | 2013 | 59 | 0.130 |
Why?
|
| Vegetables | 2 | 2014 | 147 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 149 | 0.130 |
Why?
|
| Blood Glucose | 2 | 2021 | 353 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 105 | 0.130 |
Why?
|
| Granulocytes | 1 | 2014 | 29 | 0.120 |
Why?
|
| Drinking Behavior | 1 | 2014 | 16 | 0.120 |
Why?
|
| Glycemic Index | 2 | 2011 | 8 | 0.120 |
Why?
|
| Fish Products | 1 | 2014 | 2 | 0.120 |
Why?
|
| Survival Rate | 3 | 2016 | 311 | 0.120 |
Why?
|
| Cucurbitaceae | 1 | 2014 | 5 | 0.120 |
Why?
|
| Ipomoea batatas | 1 | 2014 | 6 | 0.120 |
Why?
|
| Protein Binding | 1 | 2017 | 972 | 0.120 |
Why?
|
| Tea | 1 | 2014 | 45 | 0.120 |
Why?
|
| Spices | 1 | 2014 | 8 | 0.120 |
Why?
|
| Activities of Daily Living | 3 | 2014 | 105 | 0.120 |
Why?
|
| Seaweed | 1 | 2014 | 11 | 0.120 |
Why?
|
| Neutrophils | 1 | 2014 | 131 | 0.120 |
Why?
|
| Nutritional Sciences | 1 | 2014 | 22 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 356 | 0.120 |
Why?
|
| Water Pollution | 1 | 2013 | 12 | 0.120 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 64 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2013 | 2 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 66 | 0.110 |
Why?
|
| Genes, p16 | 1 | 2013 | 9 | 0.110 |
Why?
|
| Genes, jun | 1 | 2013 | 8 | 0.110 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Diet, Mediterranean | 1 | 2014 | 40 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2017 | 517 | 0.110 |
Why?
|
| Arteries | 1 | 2014 | 65 | 0.110 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 20 | 0.110 |
Why?
|
| Exodeoxyribonucleases | 1 | 2013 | 17 | 0.110 |
Why?
|
| Soy Foods | 1 | 2014 | 60 | 0.110 |
Why?
|
| Geriatrics | 1 | 2014 | 57 | 0.110 |
Why?
|
| Hand Strength | 2 | 2011 | 34 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2014 | 119 | 0.110 |
Why?
|
| Air Pollution | 1 | 2013 | 60 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 70 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2014 | 484 | 0.110 |
Why?
|
| Dementia | 1 | 2014 | 131 | 0.110 |
Why?
|
| Xanthophylls | 2 | 2023 | 15 | 0.100 |
Why?
|
| Fruit | 1 | 2014 | 173 | 0.100 |
Why?
|
| Canada | 3 | 2017 | 130 | 0.100 |
Why?
|
| Time Factors | 5 | 2016 | 1742 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 245 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2011 | 53 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2013 | 184 | 0.100 |
Why?
|
| Cholesterol, LDL | 2 | 2008 | 68 | 0.090 |
Why?
|
| Motor Activity | 2 | 2011 | 418 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 400 | 0.090 |
Why?
|
| Educational Status | 2 | 2023 | 313 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 562 | 0.090 |
Why?
|
| Carcinoma | 1 | 2011 | 96 | 0.090 |
Why?
|
| Micronutrients | 1 | 2010 | 44 | 0.090 |
Why?
|
| Pennsylvania | 3 | 2017 | 42 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 485 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 454 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2009 | 11 | 0.090 |
Why?
|
| Prognosis | 4 | 2015 | 739 | 0.090 |
Why?
|
| Logistic Models | 2 | 2016 | 923 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 111 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 618 | 0.080 |
Why?
|
| Triglycerides | 2 | 2009 | 138 | 0.080 |
Why?
|
| Postmenopause | 1 | 2009 | 128 | 0.080 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2008 | 5 | 0.080 |
Why?
|
| Aortography | 2 | 2019 | 10 | 0.080 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 13 | 0.080 |
Why?
|
| Diet Surveys | 2 | 2009 | 101 | 0.080 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 34 | 0.080 |
Why?
|
| Free Radicals | 1 | 2008 | 74 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 4268 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 66 | 0.080 |
Why?
|
| Carotenoids | 1 | 2008 | 70 | 0.080 |
Why?
|
| Haplorhini | 1 | 2007 | 22 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 140 | 0.080 |
Why?
|
| Lipids | 1 | 2009 | 235 | 0.080 |
Why?
|
| Textile Industry | 1 | 2007 | 2 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 312 | 0.080 |
Why?
|
| Efficiency | 1 | 2007 | 16 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 51 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 358 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 1067 | 0.070 |
Why?
|
| Confidence Intervals | 3 | 2014 | 149 | 0.070 |
Why?
|
| Probability | 1 | 2006 | 78 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2006 | 75 | 0.070 |
Why?
|
| Pedigree | 1 | 2006 | 79 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2009 | 286 | 0.070 |
Why?
|
| Research Design | 1 | 2008 | 313 | 0.070 |
Why?
|
| Neoplasms | 2 | 2014 | 1103 | 0.070 |
Why?
|
| Disabled Persons | 1 | 2006 | 65 | 0.070 |
Why?
|
| Ankle Brachial Index | 2 | 2016 | 11 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2006 | 90 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2009 | 938 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 441 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 136 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2006 | 174 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2005 | 64 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 204 | 0.060 |
Why?
|
| Eating | 1 | 2006 | 166 | 0.060 |
Why?
|
| GAP-43 Protein | 1 | 2004 | 9 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2004 | 29 | 0.060 |
Why?
|
| China | 2 | 2016 | 196 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 2004 | 37 | 0.060 |
Why?
|
| Meclizine | 1 | 2023 | 2 | 0.060 |
Why?
|
| Mycophenolic Acid | 1 | 2023 | 7 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 245 | 0.060 |
Why?
|
| Tubulin | 1 | 2004 | 88 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2017 | 894 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2023 | 58 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 935 | 0.050 |
Why?
|
| Disease Progression | 2 | 2016 | 601 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2022 | 127 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2021 | 130 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 75 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2022 | 208 | 0.040 |
Why?
|
| Depression | 1 | 2006 | 712 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 259 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1207 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1618 | 0.040 |
Why?
|
| Exercise | 2 | 2018 | 613 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1502 | 0.040 |
Why?
|
| International Cooperation | 1 | 2018 | 46 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 5913 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 45 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 172 | 0.040 |
Why?
|
| Physical Examination | 2 | 2008 | 43 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 120 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2011 | 534 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2017 | 89 | 0.040 |
Why?
|
| Histones | 1 | 2018 | 190 | 0.040 |
Why?
|
| Diastole | 1 | 2017 | 42 | 0.040 |
Why?
|
| Environment | 1 | 2018 | 138 | 0.040 |
Why?
|
| Systole | 1 | 2017 | 61 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2016 | 17 | 0.040 |
Why?
|
| Rats | 1 | 2004 | 3483 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2016 | 2026 | 0.040 |
Why?
|
| Body Composition | 1 | 2017 | 162 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2007 | 455 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 134 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 12 | 0.030 |
Why?
|
| France | 1 | 2015 | 17 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 36 | 0.030 |
Why?
|
| Australia | 1 | 2015 | 76 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 282 | 0.030 |
Why?
|
| Manometry | 1 | 2014 | 7 | 0.030 |
Why?
|
| Plethysmography | 1 | 2014 | 6 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2014 | 12 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 291 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 97 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2014 | 28 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 28 | 0.030 |
Why?
|
| Vitamin D | 1 | 2016 | 196 | 0.030 |
Why?
|
| Aorta | 1 | 2014 | 167 | 0.030 |
Why?
|
| Iceland | 1 | 2012 | 5 | 0.030 |
Why?
|
| Goals | 1 | 2012 | 30 | 0.030 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2011 | 5 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2011 | 34 | 0.020 |
Why?
|
| Thinness | 1 | 2010 | 29 | 0.020 |
Why?
|
| Homocysteine | 1 | 2010 | 19 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2010 | 19 | 0.020 |
Why?
|
| Oregon | 1 | 2010 | 43 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2010 | 27 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2010 | 19 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 46 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 107 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 103 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 268 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 112 | 0.020 |
Why?
|
| Tunica Media | 1 | 2008 | 12 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2008 | 19 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 661 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 225 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 336 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 215 | 0.020 |
Why?
|
| Psychology, Social | 1 | 2007 | 5 | 0.020 |
Why?
|
| Radiography | 1 | 2007 | 72 | 0.020 |
Why?
|
| Art | 1 | 2007 | 3 | 0.020 |
Why?
|
| Cuba | 1 | 2006 | 32 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2006 | 15 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 37 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 550 | 0.020 |
Why?
|
| Exercise Test | 1 | 2006 | 67 | 0.020 |
Why?
|
| Postural Balance | 1 | 2006 | 32 | 0.020 |
Why?
|
| Culture | 1 | 2007 | 173 | 0.020 |
Why?
|
| Walking | 1 | 2006 | 68 | 0.020 |
Why?
|
| Registries | 1 | 2007 | 335 | 0.020 |
Why?
|
| Bronchopneumonia | 1 | 2004 | 1 | 0.020 |
Why?
|
| Autopsy | 1 | 2004 | 43 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 935 | 0.020 |
Why?
|